Skip to content
Recall Observatory FDA recall evidence

Drug product

Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 0527-1632-10

D-0160-2023

November 09, 2022

Class III

Product summary

Firm
Lannett Company Inc.
Event
Event 91142
Status
Terminated
Classification
Class III
Quantity
5,640 bottles
Official record key
drug-enforcement:D-0160-2023

Official wording

Reason: Failed Impurity/Degradation Specifications

Code information: Lots: 20256318A (12/2022), 20256321A (12/2022), 21000238A (01/2023)

Distribution pattern: Nationwide USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurity/Degradation Specifications